JAMIE CRUMLEY: Open Payments
NPI 1629532387 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$650 in 26 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $40 · 2025 $650
Food & beverage: $650
| Company | Payments | Amount |
|---|---|---|
| Corium, LLC | 8 | $229 |
| Janssen Pharmaceuticals, Inc | 5 | $208 |
| E.R. Squibb & Sons, L.L.C. | 2 | $46 |
| Alkermes, Inc. | 2 | $29 |
| ABBVIE INC. | 2 | $29 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $29 |
| Braeburn Inc. | 1 | $17 |
| Axsome Therapeutics, Inc. | 1 | $17 |
| Otsuka America Pharmaceutical, Inc. | 1 | $16 |
| Lundbeck LLC | 1 | $16 |
Products named: Azstarys, SPRAVATO, COBENFY, REXULTI, ARISTADA, VRAYLAR, CAPLYTA, BRIXADI.
Industry payments across AZ — which companies pay providers there.
